VeriMom¿Es palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine seguro durante el embarazo?
Reviewed by VeriMom Editorial Team · Last reviewed
Ingredientes
palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
SIN RIESGOS CONOCIDOS100
/100
0
Pregnancy-safe products containing palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
Matte
Matte Growth Factor Serum
99/100
ISOMERS Skincare
ISOMERS Skincare Stemgenesis® Pur Orchid Concentrate
99/100
TAHNYC
TAHNYC Contour Concentrated 10 Peptide Serum
99/100
Basiclab
Basiclab Esteticus Antioxidant Compensating Serum With 20% Vitamin C
98/100
The Neo Mortal
The Neo Mortal Hand And Body Balm V6
98/100
Nécessaire
Nécessaire Hand Cream *2023 Update*
98/100
RevivSerums
RevivSerums Telomerase 6-In-1 Multi-Corrective Serum
98/100
Basiclab
Basiclab Esteticus Skin Structure Regenerating Serum with 1% Ceramides and 5% Peptides
98/100
Bigger Than Beauty
Bigger Than Beauty Light Weight Moisturizer
98/100
HighDroxy
HighDroxy Re:store Ageless
98/100
Related ingredients
Ver también
Sources & references
Authoritative references used to score this ingredient.
Frequently asked questions
- ¿Es palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine seguro durante el embarazo?
- No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
- ¿Es palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine seguro durante la lactancia?
- No data indicating transfer into breast milk or lactation-related toxicity. Given the peptide's size/polarity and expected negligible systemic absorption after topical use, risk of exposure to breastfed infants is unlikely. No regulatory flags (ECHA Annex VI, SCCS, CIR) or peer‑reviewed evidence were found.
- ¿Es palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine seguro para la piel del bebé?
- No infant‑specific reproductive or toxicology data located. Adult dermal absorption is expected negligible; however, infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, so exposure score is increased by +1 for 0–3 yr. There is still no mechanistic or hazard evidence suggesting reproductive or developmental toxicity for infants.
- ¿Cómo puntúa VeriMom a palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine?
- VeriMom puntúa palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine en el embarazo?
- Consulta nuestra lista de alternativas seguras a palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.